Related Experiment Videos
[Angiotensin converting enzyme inhibitors in arterial hypertension]
1Servicio de Cardiología, Complejo Hospitalario Universitario, Santiago de Compostela, La Coruña.
Insights
Angiotensin converting enzyme inhibitors effectively control blood pressure and reduce left ventricular hypertrophy in hypertensive patients. These drugs are crucial for managing hypertension, especially in diabetic individuals with cardiac issues.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Research
Background:
- Arterial hypertension presents significant cardiovascular risks.
- Hypertension is often associated with other pathologies like diabetes and cardiac dysfunction.
- Left ventricular hypertrophy is a common complication of the hypertensive process.
Purpose of the Study:
- To review the cardiovascular effects of angiotensin converting enzyme (ACE) inhibitors.
- To explore the mechanistic basis for the cardioprotective effects of ACE inhibition.
- To assess the role of ACE inhibitors in managing hypertension and related cardiovascular conditions.
Main Methods:
- Review of experimental and clinical studies over the past twenty years.
- Analysis of data on ACE inhibitors in patients with arterial hypertension.
- Evaluation of therapeutic outcomes in diverse patient subgroups, including those with diabetes and cardiac dysfunction.
Main Results:
- ACE inhibitors achieve significant blood pressure control as monotherapy or in combination.
- These agents are particularly indicated for hypertensive patients with diabetes and cardiac dysfunction.
- ACE inhibitors demonstrate superior efficacy in reducing left ventricular hypertrophy compared to other available drugs.
- Evidence suggests a potential role for ACE inhibitors in limiting the atherosclerotic process.
Conclusions:
- ACE inhibitors are vital in managing arterial hypertension and its cardiovascular sequelae.
- Their benefits extend to specialized populations, including diabetic patients with cardiac complications.
- ACE inhibitors represent a cornerstone therapy for reducing left ventricular hypertrophy and potentially mitigating atherosclerosis.
Abstract:
We review the different cardiovascular effects exerted by angiotensin converting enzyme inhibitors, obtained in several experimental and clinical studies in the last twenty years, in patients with arterial hypertension and different cardiovascular pathologies related to the hypertensive process. We will review the mechanistic basis of the cardiovascular protective effects of angiotensin converting enzyme inhibition. These drugs, as monotherapy or combined therapy, can achieve blood pressure control in a high proportion of hypertensive patients; in hypertensive patients with diabetes these drugs are especially indicated, and also are the drugs of choice in diabetic hypertensive patients with cardiac dysfunction due to ischaemic cardiomyopathy. This group of drugs has the highest effect among the drugs available today in reducing left ventricular hypertrophy associated with the hypertensive process. There are many experimental and clinical data that suggest the potential role of the angiotensin converting enzyme antagonists limiting the atherosclerotic process.